ARRHYTHMIA RESEARCH TECHNOLOGY, INC. and AMBU A/S Announce Exclusive Multi-Year Supply Agreement.FITCHBURG, Mass. -- Arrhythmia Research Technology, Inc. (AMEX AMEX See: American Stock Exchange : HRT HRT abbr. hormone replacement therapy Hormone replacement therapy (HRT) Also called estrogen replacement therapy, this controversial treatment is used to relieve the discomforts of menopause. ) announced that its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. Micron Products Inc. ("Micron"), has entered into an exclusive three-year supply agreement with Ambu A/S (Copenhagen: AMBU) to produce silver/silver chloride and non-silver plated conductive resin medical electrophysiolgical sensors for use in Ambu's disposable monitoring and diagnostic electrode products including the Ambu[R] Blue Sensor line of cardiac monitoring electrodes and the Ambu[R] Neuroline Cup diagnostic electroencephalographic e·lec·tro·en·ceph·a·lo·graph n. Abbr. EEG An instrument that measures electrical potentials on the scalp and generates a record of the electrical activity of the brain. Also called encephalograph. electrodes. James E. Rouse, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Arrhythmia Research Technology, Inc., commented, "We are very pleased to have been chosen by Ambu as the manufacturer of these critical components for Ambu's monitoring and diagnostic electrodes, especially the highly regarded Blue Sensor and Neuroline Cup product lines. Micron and Ambu have had a long and mutually beneficial relationship and this exclusive agreement provides stability for both companies. The joint efforts in product development and product improvement will continue to benefit both Micron and Ambu. The three-year agreement includes all current products being produced or under development." About Arrhythmia Research Technology, Inc. ART, through Micron, manufactures silver plated and non-silver plated conductive resin sensors and distributes metal snaps used in the manufacture of disposable ECG ECG electrocardiogram. ECG abbr. 1. electrocardiogram 2. electrocardiograph ECG Also called an electrocardiogram, it records the electrical activity of the heart. , EEG EEG: see electroencephalography. , EMS and TENS electrodes. Micron's NEM division manufactures custom injection molded products for medical, electronic, industrial and consumer applications. Micron's MIT MIT - Massachusetts Institute of Technology division provides end- to- end product life cycle management through a comprehensive portfolio of value-added services such as design, engineering, prototyping, manufacturing, machining, assembly and packaging. Micron's Leominster Tool division provides high end mold design and manufacturing for the injection molding industry. The Company's products also include proprietary signal-averaging electrocardiography electrocardiography (ĭlĕk'trōkärdēŏg`rəfē), science of recording and interpreting the electrical activity that precedes and is a measure of the action of heart muscles. (SAECG SAECG Signal-Averaged Electrocardiogram ) software used in the detection of potentially lethal hearth arrhythmias. For more information please check our websites: http://www.arthrt.com http://www.micronproducts.com http://www.leominstertool.com http://www.newenglandmolders.com http://www.micronintegrated.com About Ambu A/S Ambu develops, produces and markets diagnostic and life-supporting devices to hospitals and rescue services. Ambu has five business areas: Respiratory Care, Cardiology, Neurology, Training and Immobilization Immobilization Definition Immobilization refers to the process of holding a joint or bone in place with a splint, cast, or brace. This is done to prevent an injured area from moving while it heals. . The most important business areas are Respiratory Care, Cardiology and Neurology, and the most important products in these areas are ventilation products for artificial respiration and single-use electrodes for ECG recordings and neurophysiological neu·ro·phys·i·ol·o·gy n. The branch of physiology that deals with the functions of the nervous system. neu examinations. Ambu's products are sold worldwide. Exports account for 98% of sales, and sales are handled via Ambu's foreign subsidiaries or via distributors. Ambu has approx. 1,210 employees, of whom approx. 310 work in Denmark and 900 abroad. For more information please check our website: http://www.ambu.com Examples of the Products The Ambu Neuroline Cup electrode is specially designed for clinical EEG, EP and PSG PSG, n polysomnograph; polygraph performed during sleep. Physiological variables such as pulse, blood pressure, and respiration are monitored and charted. examinations. The Ambu Neuroline Single Patient Cup electrode provides consistent and superior signal quality as well as greater convenience. The use of a high quality single patient silver/silver chloride electrode ensures a high and consistent signal quality. Unique features/benefits: * Advanced silver/silver chloride sensor ensures uniform high signal quality * Pre-attached tangle-free lead wires * Colour coded lead wires for easy handling * No risk of cross-contamination The small Ambu Blue Sensor P features highly conductive wet gel and superior adhesion to ensure optimal signal quality during short- to medium-term applications. Thanks to the comfortable foam backing material, the electrode is gentle to the skin. Features: * Highly conductive wet gel * Superior adhesion * Comfortable foam backing * Unique offset concept * High-quality Ag/AgCl sensor Note Regarding Forward Looking Statements Forward-looking statements made herein are based on current expectations of the Company that involve a number of risks and uncertainties and should not be considered as guarantees of future performance. The factors that could cause actual results to differ materially include: interruptions or cancellation of existing contracts, impact of competitive products and pricing, product demand and market acceptance, risks, the presence of competitors with greater financial resources than the Company, product development and commercialization risks, changing economic conditions in developing countries, and an inability to arrange additional debt or equity financing. More information about factors that potentially could affect the Company's financial results is included in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2005. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion